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The human serotonin (5-hydroxytryptamine, 5-HT) transporter
(hSERT, SLC6A4) figures prominently in the etiology and treatment
of many prevalent neurobehavioral disorders including anxiety,
alcoholism, depression, autism, and obsessive-compulsive disorder
(OCD). Here, we use naturally occurring polymorphisms in recom-
binant inbred (RI) lines to identify multiple phenotypes associated
with altered SERT function. The widely used mouse strain C57BL/
6J, harbors a SERT haplotype defined by 2 nonsynonymous coding
variants [Gly-39 and Lys-152 (GK)]. At these positions, many other
mouse lines, including DBA/2J, encode, respectively, Glu-39 and
Arg-152 (ER haplotype), amino acids found also in hSERT. Ex vivo
synaptosomal 5-HT transport studies revealed reduced uptake
associated with the GK variant, a finding confirmed by in vitro
heterologous expression studies. Experimental and in silico ap-
proaches using RI lines (C57BL/6J  DBA/2J  BXD) identify
multiple anatomical, biochemical, and behavioral phenotypes spe-
cifically impacted by GK/ER variation. Among our findings are
several traits associated with alcohol consumption and multiple
traits associated with dopamine signaling. Further bioinformatic
analysis of BXD phenotypes, combined with biochemical evalua-
tion of SERT knockout mice, nominates SERT-dependent 5-HT
signaling as a major determinant of midbrain iron homeostasis
that, in turn, dictates iron-regulated DA phenotypes. Our studies
provide an example of the power of coordinated in vitro, in vivo,
and in silico approaches using mouse RI lines to elucidate and
quantify the system-level impact of gene variation.
gene  haplotype  iron  serotonin  dopamine
A complex set of phylogentically conserved traits relies uponthe production, secretion, and inactivation of the biogenic
amine 5-HT (1). A critical and conserved mechanism to regulate
5-HT signaling involves the action of the presynaptic 5-HT
transporter, SERT (2). SERTs are not only responsible for the
clearance of 5-HT after release, but also recycle synaptic 5-HT
to sustain adequate stores for 5-HT release (3).
The recognition of the central role played by SERT in 5-HT
inactivation has been reinforced by studies where mouse SERT
(mSERT) has been eliminated (4), suppressed (5, 6), or en-
hanced (7). Although investigations with these models provide
critical support for a role of SERT in presynaptic 5-HT clearance
and homeostasis, inferences linking SERT to neural signaling
and behavior are complicated by significant compensatory
changes in other genes (8). Conversely, a lack of recognition for
background genetic diversity in mouse strains likely limits the full
elaboration of phenotypes associated with SERT genetic varia-
tion (9). Indeed, SERT knockout mice display different pheno-
types depending on their genetic background (10).
An alternative approach is the identification of traits that are
sensitive to naturally occurring polymorphisms using genetic
reference populations, such as BXD recombinant inbred (RI)
lines (11). BXD RI lines are isogenic, homozygous mosaics of
C57BL/6J and DBA/2J inbred strains, previously created by
inbreeding F2 intercross progeny. Conventionally, these popu-
lations are used in forward genetic screens to discover unknown
polymorphisms affecting a trait. Here we analyze RI lines that
share specific 5-HT gene variants against an otherwise random-
ized genetic background, an advantage over approaches that test
allele effects on one or two inbred backgrounds (11–13). Perhaps
the greatest strength of this approach is the availability of
archived, dimensional data across a large number of phenotypes
linked to individual BXD lines (14, 15), including anatomical,
neurochemical, and behavioral traits. In this report, we initiate
investigation of naturally occurring variation in 5-HT genes via
analysis of functional coding polymorphism in mSERT. Further-
more, as this archive is a freely accessible, expanding resource,
appreciation for how SERT and 5-HT-linked gene variants
impact physiology can be increasingly enriched as additional phe-
notypes are registered. This integrative approach to reverse genetics
of identified polymorphisms should also be applicable to more
powerful genetic reference populations (13, 16, 17).
Our report initiates with an analysis of the distribution among
laboratory mouse strains, followed by neurochemical analyses of
SERT function in synaptosomes from several standard inbred
lines. Subsequently, we confirm reduced 5-HT transport mSERT
phenotype associated with the GK variant in a heterologous
expression system. Controlling for Tph2 variation, we replicate
haplotype effects in vivo using select BXD lines then exploit the
BXD population to expand analyses to anatomical, biochemical,
and behavioral phenotypes. Through this approach, we docu-
ment multiple SERT-sensitive phenotypes and elucidate a con-
nection to iron homeostasis that we propose links 5-HT signaling
to dopamine (DA) modulated behaviors.
Results
Identification of Slc6a4 Coding Variation in Inbred Mouse Lines.
Analysis of Slc6a4 DNA sequences from 40 mouse inbred lines
deposited in the Mouse Phenome database (http://aretha.jax.
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org/pub-cgi/phenome/mpdcgi?rtn  docs/home) revealed a hap-
lotype consisting of 2 nonsynonymous SNPs (Fig. 1A and C) that
distinguish C57BL/6J, C57BL/10J, C57BL/10ScSr, C57BR/cdJ,
C57L/J, PERC/EiJ, and RBA/DnJ strains from other mouse
lines. We confirmed mSERT variation using a PCR-RFLP-based
strategy (see Fig. 1D and Table S1) and by direct sequencing of
Slc6a4 in selected lines. The first transition (rs13481111) con-
verts the highly conserved amino acid Glu-39 (gag) within the
mSERT cytosolic NH2 terminus to Gly (ggg) (Fig. 1 A and C).
The second transition (rs29413009) converts an Arg codon (agg)
to one encoding Lys (aag) at amino acid 152 in the transporter’s
first intracellular loop (Fig. 1 A and C). These 2 variants
constitute a distinct haplotype (hereafter denoted as mSERT
ER or GK) as they have not segregated in the establishment of
inbred mouse lines, consistent with their separation by only 2,476
bp of genomic sequence.
Characterization of the Slc6a4 Haplotype in Inbred Mouse Lines. For
initial inspection of functional differences between mSERT ER
and GK, we compared 5-HT uptake rates in midbrain synapto-
somes prepared from multiple strains discordant for the 2
haplotypes, but concordant for the same, high functioning Tph2
genotype, a potentially confounding factor (18) (Table S1).
Strains bearing the GK haplotype (C57BL/6J and C57BL/10J)
demonstrated significantly reduced 5-HT uptake as compared
with strains carrying the ER haplotype (CBA/J, 129/SvJ, and
C57BLKS/J) (Fig. 1E, nested ANOVA, F(1, 3)  12.21, P 
0.039, 2  0.61). These functional differences could not be
attributed to changes in mSERT density, as levels of [3H]par-
oxetine binding did not differ across strains (Fig. 1f, nested
ANOVA, F(1, 3)  6.34, P  0.086). Haplotype-associated
differences in midbrain mSERT activity could not be ascribed to
general alterations in ion gradients or membrane potential
because no differences were observed in dopamine or norepi-
nephrine transport across the same preparations (Fig. S1 A).
Consistent with the identity of the Tph2 isoforms across these
lines, we also found no differences in midbrain or cortical 5-HT
or 5-HIAA tissue levels that might account indirectly for uptake
differences (Fig. S1B).
Characterization of Coding Variants in mSERT-Transfected HEK-293
Cells. Unknown genetic variation that cosegregates with ER/GK
could underlie the differences in 5-HT uptake in synaptosomes.
We therefore monitored mSERT activity in HEK-293 cells
transfected with full-length transporter cDNAs. Here again,
kinetic analyses revealed significantly lower SERT activity as-
sociated with the GK haplotype (Fig. 2A, 2-way ANOVA, P 
0.0001, n  6, 2  0.17), with changes arising from a significant,
4-fold reduction in 5-HT transport VMAX (Fig. 2B; ER, 4414 
715 fmol/min, n  6; GK, 1219  274 fmol/min n  6, unpaired
Student’s t test, P  0.01, Cohen’s d  2.77) but no discernible
haplotype impact on 5-HT transport KM (ER, 2.970  0.808; GK,
1.041  0.056). As with inbred line studies, no overall differences
in total mSERT expression were observed either by Western
blots or by membrane binding assays using the cocaine analog
[125I]RTI-55 (data not shown). These measures yield an estimate
of SERT catalytic rate of GK SERT 50% that of ER SERT.
Analysis of cDNAs expressing individual variants indicates that
the reduced SERT activity of the GK haplotype arises from the
Glu-39 substitution (Fig. 2A, 2-way ANOVA, P  0.0001, n  6,
2  0.15, Bonferroni’s post hoc test, P  0.05).
Impact of Slc6a4 Variation in Recombinant Inbred Mouse Lines Con-
cordant for the Pro-447 Tph2 Allele. To establish a systems-level
evaluation of 5-HT genetic variation, we extended our investi-
gation of mSERT GK/ER-associated phenotypes to (BXD)
lines. By determining the status of RI strains for Slc6a4 and Tph2
Fig. 1. Identification of a naturally occurring Slc6a4 haplotype in inbred
mouse lines. (A) Schematic illustration of the location of the Slc6a4 SNPs
characterized in this study. (B) Alignment of SERT protein sequences from
human, macaque, rat, mouse, sheep, and fruit fly. (C) Alignment of National
Center for Biotechnology Information mSERT protein sequences with
Glu39Gly and Arg152Lys polymorphisms indicated by arrows. (D) Genotyping
by PCR-RLFP of C57BL/6J, C57BLKS/J, C57BL/10J, C58/J, 129  1/SvJ, CBA/J,
BALB/cJ, and DBA/2J mice. Digestion of a 540-bp band by HaeIII with a
generation of a 350-bp band indicates G (Gly) allele in the Glu39Gly SNP. The
213-bp amplicon generated by PCR was subjected to restriction digestion with
MnlI to detect the G SNP (Arg) resulting in a digestion product of 82 for the R
allele or 115 for the K allele. (E) Midbrain 5-HT synaptosomal uptake in ER
(CBA/J, 129/SvJ, and C57BLKS/J) and GK (C56BL/6J and C57BL/10J) lines. (F)
Midbrain [3H]paroxetine binding in ER (CBA/J, 129/SvJ, and C57BLKS/J) and GK
(C56BL/6J and C57BL/10J) lines.
Fig. 2. Functional characterization of mSERT coding variation in HEK-293
cells. (A) Saturation kinetic studies show a reduced 5-HT uptake in cells
transfected with the 39G single mutation (Œ) and 39G and 152K double
mutation (GK, ) when compared with the 39E, 152R isoform found in most
inbred mouse lines (ER, ■ ). (B) Scatchard plot of ER and GK data generated
from saturation uptake analysis. Data presented as means  SEM from 6
independent experiments.
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variants, we were able to identify and acquire 27 BXD strains
concordant for the common, high-functioning C57BL/6J Tph2
allele (Pro-447) that could be divided into 13 lines with the
Slc6a4 DBA/2J ER haplotype (nos. 9, 11, 31, 39, 40, 45, 50, 56,
63, 66, 75, 76, 83) and 14 lines with the Slc6a4 C57BL/6J GK
haplotype (nos. 43, 44, 48, 51, 60, 61, 67, 69, 73, 77, 90, 92, 96,
97). We prepared midbrain and forebrain synaptosomes from 7
lines of each Slc6a4 haplotype and determined SERT activity.
BXD RI lines bearing the GK haplotype demonstrated reduced
5-HT uptake in midbrain and forebrain synaptosomes (mixed
model, likelihood ratio test (LRT) of genotype effect across
brain areas, 2 (df  1)  3.95, P  0.047, 2  0.25) (Fig. 3A).
As expected, 5-HT uptake was significantly higher in midbrain
than in forebrain (LRT 2 (df  1)  6.65, P  0.010, 2  0.07)
and genotype was equally penetrant in both brain regions (i.e.,
interaction was not significant, LRT 2 (df  1)  0.01, P 
0.932) (Fig. 3A). These findings reinforce our conclusion that the
Slc6a4 GK haplotype exhibits reduced 5-HT transport activity.
We assessed BXD lines bearing GK and ER for differences in
levels of 5-HT and metabolites. Although again no significant
differences were found (data not shown), tissue measurements
of neurotransmitters are a fairly insensitive indication of synaptic
5-HT availability and action. We therefore sought a behavioral
readout known to be sensitive to SERT function (19, 20). We
tested BXD lines in marble burying, nestlet shredding, basal tail
suspension, and open field tests, each known to be sensitive to
selective serotonin reuptake inhibitor (SSRI) drugs or SERT
ablation (10, 20, 21). Although no significant differences be-
tween ER and GK lines were detected in either marble burying
or nestlet shredding behaviors (Fig. S2), lines expressing the
reduced function GK variant exhibited significantly decreased
basal tail suspension immobility (Fig. 3b, unpaired Student’s t
test, P  0.037, Cohen’s d  0.88). Immobility in the tail
suspension test (TST) is believed to reflect diminished capacity
for stress-alleviating behaviors, and reduced SERT function
achieved with acute SSRI treatment decreases immobility (22).
Despite differences in basal TST immobility, sensitivity to
citalopram (20 mg/kg) appeared identical between genotypes
(shown as % reduction in immobility over saline, Fig. 3C). When
we tested GK and ER lines for their locomotor response to an
open field, we found horizontal activity to be indistinguishable
(Fig. 3D), suggesting a lack of impact of mSERT variants on
overall motor function or psychomotor activation. Nonetheless,
GK lines differed from ER lines in time spent in the chamber
center, often considered a measure of anxiety (Fig. 3 E and F,
unpaired Student’s t test, P  0.020, Cohen’s d  0.79).
In Silico Identification of Phenotypes Influenced by Slc6a4 Coding
Variation. To identify unique phenotypes affected by ER/GK
variation, we performed an in silico analysis of 843 archived
BXD phenotypes registered at Genenetwork.org (11) including
anatomical, biochemical, and behavioral traits. We analyzed trait
dependence on genotype using a 2-gene model comprising
independent effects of the Slc6a4 ER/GK and Tph2 Arg447Pro
variants and allowing for gene–gene interaction. Fig. S3 shows
phenotypes more associated with the independent effects of the
mSERT GK haplotype, and include several traits linked to
alcohol sensitivity or tolerance, including mean and total ethanol
consumption and ethanol-conditioned taste aversion, consistent
with previous findings in SERT knockout mice (23, 24). Traits
influenced by interactions of Slc6a4 and Tph2 variants are
provided in Table S2 (independent Tph2-associated traits are
presented in Table S3).
An assessment of archived biochemical traits revealed the GK
haplotype to be associated with ventral midbrain dopamine D2
receptor (Drd2) expression, and caudate-putamen dopamine
transporter (Slc6a3) density (Fig. 4 A and B). Interestingly, a
prior analysis has revealed that these (and other) DA-related
phenotypes are associated with midbrain iron levels (25). Con-
sistent with these findings, the GK mSERT haplotype associates
significantly with elevated iron levels in both the region of DA
cell bodies (ventral midbrain) and DA terminal fields (caudate-
putamen) (Fig. 4 C and D).
To test whether the changes observed in iron levels are the
result of genetic variation in SERT vs. that of a gene in linkage
disequilibrium, we measured brain iron levels in Slc6a4/ (KO)
mice. SERT KO mice exhibit significantly reduced midbrain iron
levels (Fig. 4D, /: 4.123  0.5349 n  11; /: 6.678  0.3762
n  8, unpaired t test P  0.005, Cohen’s d  1.53). Hippocampal
tissue did not differ in iron levels (/: 8.973  1.327 n  12;
/: 8.466  1.644 n  10, unpaired t test, P  0.810).
Discussion
In this study, we characterize a naturally occurring haplotype in
the mSERT gene, where Gly-39 and Lys-152 replace Glu-39 and
Arg-152, respectively. Our findings are of general relevance in
that they illustrate an integrative approach to identifying quan-
titative phenotypes influenced by mouse genetic variation. More
specifically, our findings capitalize on naturally occurring vari-
ation in mSERT to establish a platform for associating molecular
and system level phenotypes of 5-HT signaling genes.
RI lines with the mSERT GK haplotype displayed reduced
basal immobility in the TST, consistent with ex vivo and trans-
fected cell studies that identify reduced SERT activity with the
GK variant. Nonetheless, the reduced SERT activity in the GK
lines is still adequate for acute potentiation of 5-HT signaling by
Fig. 3. Characterization of mSERT ER/GK haplotypes in recombinant inbred
BXD lines. (A) Reduced midbrain and forebrain 5-HT uptake in GK RI mouse
lines compared with EK RI mouse lines. (B) Reduced basal immobility time in
GK RI mouse lines compared with ER RI mouse lines. (C) ER and GK mouse lines
have similar sensitivity to the SSRI citalopram (20 mg/kg) as assessed by TST (EK,
n  88 mice; GK, n  71 mice). (D) Basal locomotor behavior is not altered in
GK lines. (E) GK RI lines spend less time in the center of the open field
apparatus than ER lines over a 90-min period. (F) Novel open field test for
exploratory activity shows reduced time in the center for mice bearing the GK
Slc6a4 .
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an SSRI (citalopram). One might expect that reduced SERT
activity might have resulted in altered citalopram responsive-
ness; however, the dosage of citalopram optimized for responses
in the TST paradigm may simply be above that required to
distinguish SSRI sensitivities in vivo, although it should also be
noted that the variants are not located in the predicted binding
pocket for citalopram (26, 27). We also found equivalent cita-
lopram recognition by GK/ER variants in our transfection
studies (Fig. S4).
A larger physiological significance of mSERT GK/ER variation
becomes most evident via inspection of archived phenotypes asso-
ciated with lines segregating the ER/GK haplotype. An important
strength of this approach is that traits assessed in this paradigm do
not derive from a priori functional hypotheses, although by neces-
sity they reflect the interests of the research community using RI
lines. In this effort, we found a significant impact of the GK
haplotype on body weight, confirmed by our own assessments (data
not shown) and the known anorexigenic action of elevated extra-
cellular 5-HT (28, 29). We were struck by the multiple associations
between the GK haplotype and ethanol-related behaviors, where
the GK low-uptake activity is associated with lower ethanol con-
sumption and acceptance. In humans, individuals with the low-
functioning S allele of the 5HTTLPR, and presumably increased
synaptic 5-HT availability, demonstrate lower voluntary ethanol
consumption (30, 31). These findings also point to further utility of
gene  environment designs in analysis of the functional impact of
the ER/GK haplotype.
Possibly, the associations of the ER/GK haplotype with eth-
anol sensitivity/consumption traits relate to a more global mod-
ulation of reward pathways, such as those through which DA
signaling modulates reinforcement. Consistent with this idea, we
found the ER/GK haplotypes to associate with altered DAT and
D2 receptor expression. DAT and D2 receptor expression are
known to be under significant genetic influence (29, 32). Im-
portantly, serotonergic innervation regulates both somatic DA
neuron excitability and terminal field DA release (33, 34).
Although it is reasonable to expect that ER/GK haplotype-driven
differences in SERT activity impact DA signaling directly, we
identified an indirect pathway involving midbrain iron homeostasis
that may have even larger significance. A 3-way association between
SERT, iron, and dopaminergic traits cannot alone define epistatic
relationships. However, our evaluation of SERT knockout mice,
where we observed a significant reduction in midbrain iron levels
in SERT KO mice relative to controls, raises the possibility that
5-HT signaling has a significant effect on dopaminergic traits via the
control of mesencephalic and basal ganglia iron homeostasis. The
rate-limiting step in the production of dopamine is the activity of
tyrosine hydroxylase, an iron-requiring enzyme (35, 36). Addition-
ally, 5-HT, acting via 5-HT2C receptors in the choroid plexus,
regulates transferrin receptor expression (37). Region-specific al-
terations in iron homeostasis in SERT KO mice indicate additional
factors key to iron sequestration that may also be differentially
impacted by 5-HT signaling. Importantly, dietary iron reductions
produce reversible reductions in CNS DAT and D2 receptor
expression (38, 39).
An important, additional strength of studies examining nat-
ural gene variation in murine RI strains, is the opportunity to
characterize the impact of genetic interactions in defining com-
plex traits. For example, BXD lines also exhibit functional
variation at the locus encoding the enzyme responsible for CNS
5-HT synthesis, Tph2 (18). C57BL/6J inbred mice express the
high-functioning Tph2 allele and, as we have shown, a low-
functioning SERT variant. Synaptically, this would suggest that
in C57BL/6J, high levels of 5-HT production and release are
accompanied by relatively low rates of 5-HT clearance. In
contrast, DBA/2J mice express the low-functioning Tph2 Arg-
447 variant in the context of a high-functioning mSERT ER
variant. Here, the predicted effect is relatively reduced 5-HT
synthesis and release in the context of high 5-HT clearance
capacity. Together, these allelic combinations are predicted to
drive ceiling and floor levels of synaptic 5-HT in B and D RI
lines, respectively. The designation of mSERT and Tph2 variants
in these lines is but one example of an advancing sophistication
in our understanding of how to model 5-HT impact on complex
traits, many of which are routinely used to model components of
neuropsychiatric disease risk and the effects of medications
(40, 41).
Experimental Procedures
Cell Transfections and Transport Assays. The Stratagene QuikChange kit was
used to generate the coding mutants in the mSERT/pcDNA3.1. Mutants were
confirmed by fluorescent DNA sequencing (Center for Molecular Neuro-
science, Neurogenomics and Sequencing Core Facility, Vanderbilt University
Nashville, Tennessee). HeLa cells were transfected and [3H] 5-HT uptake was
performed as previously described (42). KM and VMAX values obtained from
evaluation of transport activity were derived using a nonlinear curve fit as a
function of 5-HT concentration (100 nM to 10 M) (Prism4 for PC, Graphpad
software). We normalized total uptake data by the mSERT expression levels
obtained by Western blot analysis of each individual experiment. All experi-
ments were performed in triplicate and repeated in 6 or more separate assays.
Synaptosomal Uptake and Binding. Mouse studies were performed in accor-
dance with humane guidelines established by the Vanderbilt Institutional
Animal Care and Use Committee (IACUC) under an approved protocol (M/04/
376). Inbred mice were obtained from The Jackson Laboratory (Bar Harbor,
Maine) and killed at 8–10 weeks of age. BXD male mice were obtained from
the University of Tennessee Health Science Center and Oak Ridge National
Laboratory. Brain tissue was dissected and homogenized for synaptosomal
uptake and binding as described previously (43). The following BXD lines were
used: ER lines: 44, 61, 60, 77, 90, and 97 (n  26) and GK lines: 83, 75, 40, 66,
31, 76, and 56 (n  24).
Tail Suspension Test. Basal TST was performed manually by 2 independent
researchers blind to genotype. Each mouse was suspended by its tail and total
Fig. 4. DA phenotypes and brain iron levels are influenced by SERT gene
variation. (A and B) DA-signaling phenotypes: D2 receptor expression in
ventral midbrain (10591541) and DAT expression in caudate-putamen
(10591541). (C and D) GK () lines have increased ventral midbrain iron levels
in both caudate-putamen and midbrain when compared with ER (■ ) lines. (E)
Slc6a4/ mice () have reduced midbrain iron levels when compared with
wild-type controls (■ ). Unpaired Student’s t test P values are indicated above
bars.
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duration of immobility was calculated as the time the mouse became immo-
bile during a 6-min test session. Mice that either climbed the apparatus or
failed to exhibit immobility were removed from the analysis. For analysis of
basal TST, unpaired Student’s t tests were used to compare in 7 GK BXD lines
(nos. 31, 40, 56, 66, 75, 76, and 83; n  23) and 7 ER BXD lines (nos. 44, 60, 61,
77, 90, 96, and 97; n  26). For the SSRI sensitivity studies, we used the BXD
lines: nos. 89 ,61, 69, 51, 90, 48, 67, 97, 43, 92 (ER, n  88) and 66, 75, 50, 11,
9, 40, 31, 45, 39, 63 (GK, n  71). Racemic citalopram hydrobromide was
prepared fresh daily by dissolving the powder in deionized water. Drug was
administered by i.p. injection in a volume of 0.01 mL/g body weight and the
dose was 20 mg/kg calculated as the weight of the base. Control animals
received injections of 0.9% saline in a volume of 0.01 mL/g. Each mouse was
tested twice in the TST: once with saline and once with citalopram, 1 week
apart. A counterbalanced design was used, where half of the animals received
saline followed by citalopram and the other half received citalopram followed
by saline. Mice were injected with drug or saline 30 min before a 6-min tail
suspension test. An automated TST device (Med Associates, St. Albans, Ver-
mont) was used to measure the duration of behavioral immobility. Mice were
suspended by the tail with tape to a vertical aluminum bar connected to a
strain gauge. The following settings were used in all experiments: threshold
1, 7; gain, 8; time constant, 0.25; and resolution, 200 ms.
Open Field Activity Test. Exploratory locomotor activity was evaluated using
commercially available 27.9  27.9 cm activity monitors (MED Associates,
Georgia, Vermont) in standard fluorescent light. Mice were placed in the
monitors 90 min and allowed to explore freely. Data were exported in 10-min
time bins over 90 min and 1-min time bins during the first 10 min. For analysis,
unpaired Student’s t tests were used, comparing the cumulative data obtained
in the first 10 min of activity. BXD lines with the GK haplotype were nos. 11,
31, 39, 40, 45, 50, 63, 66, and 75 (n  53). BXD lines with the ER haplotype were
nos. 43, 48, 51, 61, 67, 69, 73, 89, 90, 92, 97 (n  86).
In Silico Analysis of BXD Phenotypes. Eight hundred forty-three BXD recom-
binant inbred phenotypes were downloaded from Genenetwork.org (August
2007) and tested for association with the functional GK/ER Slc6a4 haplotype
and the Arg447Pro Tph2 SNP. The genotype for the gene Tph2 was inferred
from the marker rs4228477. Both an epistatic linear model (ANOVA) and an
additive linear model for genotypes at rs13481111 and rs4228477 were ex-
amined for phenotypes with 12 or more strains measured (average 24 strains
total, average 6 per genotype combination). We set the cutoff for interest at
an alpha of 0.05 for model omnibus tests, because of the exploratory nature
of this aspect of the study (data shown in Fig. S3 and Tables S2 and S3). The
phenotypes that were significantly altered by mSERT haplotype were then
tested in unpaired t tests, as shown in Fig. S3.
Brain Region Iron Analysis. Tissue iron concentrations were measured with
graphite furnace atomic absorption spectroscopy (Varian AA240, Varian).
Brain regions were digested in ultrapure nitric acid (1:10 wt/vol dilution) for
48–72 h in a sand bath (60°C). An aliquot of 50 L of digested tissue was
brought to 1 mL of total volume with 2% nitric acid and analyzed for Fe.
Bovine liver (National Bureau of Standards, U.S. Department of Commerce,
Washington, DC) (10 g of Mn/g; 184 g of Fe/g) was digested in ultrapure
nitric acid and used as an internal standard for analysis (final concentration 92
g of Fe/L) to ensure consistency between runs.
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